Company: TEAM
Filing Date: 2025-05-02
Form Type: 10-Q
Source: 0001650372-25-000022
Chunk: 26

Company: Atlassian Corp
Filing Date: 2025-05-02
Form: 10-Q
Item: Part I, Item 1
Chunk 26
---
 per share, basic164,65298,019157,710102,007162,41599,008155,676103,062Conversion of shares of Class B Common Stock to Class A Common Stock outstanding—102,007—————RSA——300—————Dilution from dilutive securities——1,761—————Weighted-average shares used in computation net income (loss) per share, diluted164,65298,019261,778102,007162,41599,008155,676103,062Net income (loss) per share, diluted$(0.27)$(0.27)$0.05 $0.05 $(0.89)$(0.89)$(0.40)$(0.40)The potential weighted average dilutive securities that were not included in the dilutive earnings per share calculation because the effect would be anti-dilutive are as follows (shares in thousands):Three Months Ended March 31,Nine Months Ended March 31,2025202420252024Class A Common Stock restricted stock units6,5224,2857,9067,541Class A Common Stock restricted stock awards32—3322Total6,5544,2857,9397,563

23

14. Income TaxesThe Company computes its provision for income taxes by applying the estimated annual effective tax rate to year-to-date ordinary income and adjusts the provision for income taxes for discrete tax items recorded in the period. In each quarter, the Company updates the estimated annual effective tax rate and makes a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to volatility due to several factors, including changes in the Company’s relative proportion of domestic and foreign earnings, current cash taxes in jurisdictions with valuation allowances, material discrete tax items, or a combination of these factors as a result of certain transactions or events.The Company reported an income tax provision of $63.5 million and $148.1 million for the three and nine months ended March 31, 2025, respectively, as compared to an income tax provision of $7.0 million and $72.3 million for the three and nine months ended March 31, 2024, respectively. The income tax provision for the three and nine months ended March 31, 2025 was primarily attributable to the mix of earnings and losses at various jurisdictions, non-deductible stock-based compensation in certain foreign jurisdictions, and valuation allowances in the U.S. and Australia, offset by research and development tax